These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6168053)

  • 21. Allospecific suppression without requirement for participation of Ly 2+ cells.
    Holán V; Mitchison NA
    Immunology; 1984 Mar; 51(3):469-75. PubMed ID: 6199292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Th2-like effectors may function as antigen-specific suppressor cells in states of transplantation tolerance.
    Lowry RP; Takeuchi T; Cremisi H; Konieczny B
    Transplant Proc; 1993 Feb; 25(1 Pt 1):324-6. PubMed ID: 8438319
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanisms of specific unresponsiveness to allografts.
    Hall BM
    Transplant Proc; 1984 Aug; 16(4):938-43. PubMed ID: 6235654
    [No Abstract]   [Full Text] [Related]  

  • 24. Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient.
    Zheng SG; Meng L; Wang JH; Watanabe M; Barr ML; Cramer DV; Gray JD; Horwitz DA
    Int Immunol; 2006 Feb; 18(2):279-89. PubMed ID: 16415106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infectious tolerance develops after intrathymic alloantigen-induced acceptance of rat heart allografts can be adoptively transferred.
    Takayashiki T; Asakura H; Ku G; Kataoka M; Flye MW
    Surgery; 2005 Aug; 138(2):254-60. PubMed ID: 16153434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4-positive suppressor cells block allotransplant rejection.
    Yin D; Fathman CG
    J Immunol; 1995 Jun; 154(12):6339-45. PubMed ID: 7759872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory T cells after organ transplantation: where does their action take place?
    Dijke IE; Weimar W; Baan CC
    Hum Immunol; 2008 Jul; 69(7):389-98. PubMed ID: 18638654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8+ gammadelta T regulatory cells mediate kidney allograft prolongation after oral exposure to alloantigen.
    Zhou J; Appleton SE; Stadnyk A; Lee TD; Nashan BA
    Transpl Int; 2008 Jul; 21(7):679-87. PubMed ID: 18435686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressor cells in transplantation tolerance. I. Analysis of the suppressor status of neonatally and adoptively tolerized rats.
    Dorsch S; Roser B
    Transplantation; 1982 May; 33(5):518-24. PubMed ID: 6211808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spleen mixed leukocyte chimerism and induction of tolerance in rat renal allograft recipients conditioned with donor-specific blood transfusions and cyclosporine.
    Llull R; Mañez R; Domenech N; Starzl TE; Black KS; Hewitt CW
    Transplant Proc; 1995 Aug; 27(4):2374-6. PubMed ID: 7652844
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
    Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
    Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction.
    Orloff MS; DeMara EM; Coppage ML; Leong N; Fallon MA; Sickel J; Zuo XJ; Prehn J; Jordan SC
    Transplantation; 1995 Jan; 59(2):282-8. PubMed ID: 7839452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No coronary atherosclerotic changes were found after heart transplantation in tolerance-induced rats.
    Ito H; Hamano K; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
    Transplant Proc; 1996 Jun; 28(3):1823. PubMed ID: 8658900
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of cyclosporin A on human lymphocyte responses in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell.
    Hess AD; Tutschka PJ; Santos GW
    J Immunol; 1981 Mar; 126(3):961-8. PubMed ID: 6450807
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppressor cell induction in donor-specific transfused mouse heart recipients.
    Shelby J; Wakely E; Corry RJ
    Surgery; 1984 Aug; 96(2):296-301. PubMed ID: 6235611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulating rejection with cell therapy.
    Sayegh MH; Weiner HL
    Nat Biotechnol; 2008 Feb; 26(2):191-2. PubMed ID: 18259174
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanisms of cardiac allograft prolongation by cyclosporin-A.
    Hutchinson IF; Shadur CA; Duarte A; Baldwin WM; Strom TB; Tilney NL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):412-3. PubMed ID: 6455797
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of CD25- regulatory T cells following heart transplantation: evidence for transfer of long-term survival.
    Degauque N; Lair D; Braudeau C; Haspot F; Sébille F; Dupont A; Merieau E; Brouard S; Soulillou JP
    Eur J Immunol; 2007 Jan; 37(1):147-56. PubMed ID: 17171754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Suppression of IgE antibody production provoked by intravenous injection of antigen-pulsed heterogenetic spleen cells--a study on genetic regulation in induction of immediate tolerance and suppressor cells].
    Yagi S
    Arerugi; 1983 Apr; 32(4):199-208. PubMed ID: 6227307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.